SonoScape Medical Corp (300633) - Total Liabilities

Latest as of September 2025: CN¥996.87 Million CNY ≈ $145.87 Million USD

Based on the latest financial reports, SonoScape Medical Corp (300633) has total liabilities worth CN¥996.87 Million CNY (≈ $145.87 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300633 cash flow metrics to assess how effectively this company generates cash.

SonoScape Medical Corp - Total Liabilities Trend (2012–2024)

This chart illustrates how SonoScape Medical Corp's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of SonoScape Medical Corp to evaluate the company's liquid asset resilience ratio.

SonoScape Medical Corp Competitors by Total Liabilities

The table below lists competitors of SonoScape Medical Corp ranked by their total liabilities.

Company Country Total Liabilities
Zhejiang Southeast Space Frame Co Ltd
SHE:002135
China CN¥15.02 Billion
HuBei SanFeng Intelligent Conveying Equipment Co Ltd
SHE:300276
China CN¥2.29 Billion
Huludao Zinc Industry Co Ltd
SHE:000751
China CN¥6.44 Billion
FLEX LNG Ltd
NYSE:FLNG
USA $1.90 Billion
Greattown Holdings Ltd A
SHG:600094
China CN¥5.96 Billion
Focus Technology Co Ltd
SHE:002315
China CN¥1.64 Billion
Guangzhou Zhiguang Electric Co Ltd
SHE:002169
China CN¥6.93 Billion
CBIZ Inc
NYSE:CBZ
USA $2.67 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down SonoScape Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300633 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.32 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SonoScape Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SonoScape Medical Corp (2012–2024)

The table below shows the annual total liabilities of SonoScape Medical Corp from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥1.20 Billion
≈ $176.30 Million
+92.62%
2023-12-31 CN¥625.46 Million
≈ $91.52 Million
-22.25%
2022-12-31 CN¥804.41 Million
≈ $117.71 Million
+20.93%
2021-12-31 CN¥665.18 Million
≈ $97.34 Million
-26.66%
2020-12-31 CN¥906.93 Million
≈ $132.71 Million
-10.22%
2019-12-31 CN¥1.01 Billion
≈ $147.81 Million
+92.52%
2018-12-31 CN¥524.67 Million
≈ $76.78 Million
+90.15%
2017-12-31 CN¥275.93 Million
≈ $40.38 Million
-6.92%
2016-12-31 CN¥296.44 Million
≈ $43.38 Million
-19.78%
2015-12-31 CN¥369.52 Million
≈ $54.07 Million
-10.63%
2014-12-31 CN¥413.48 Million
≈ $60.51 Million
+58.62%
2013-12-31 CN¥260.67 Million
≈ $38.14 Million
-3.31%
2012-12-31 CN¥269.59 Million
≈ $39.45 Million
--

About SonoScape Medical Corp

SHE:300633 China Medical Devices
Market Cap
$1.52 Billion
CN¥10.42 Billion CNY
Market Cap Rank
#7388 Global
#1800 in China
Share Price
CN¥24.08
Change (1 day)
-0.25%
52-Week Range
CN¥23.43 - CN¥36.61
All Time High
CN¥60.46
About

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image process… Read more